vs
Amarin Corp plc（AMRN）与Strawberry Fields REIT, Inc.（STRW）财务数据对比。点击上方公司名可切换其他公司
Amarin Corp plc的季度营收约是Strawberry Fields REIT, Inc.的1.1倍（$45.1M vs $40.1M），Strawberry Fields REIT, Inc.净利率更高（5.0% vs -23.3%，领先28.3%），Strawberry Fields REIT, Inc.同比增速更快（31.5% vs 7.0%），过去两年Strawberry Fields REIT, Inc.的营收复合增速更高（20.0% vs -18.3%）
Amarin是一家1993年成立的爱裔美籍生物制药企业，总部分别设于爱尔兰都柏林与美国新泽西州布里奇沃特。该企业专注研发及销售心血管疾病治疗药物，已推出处方级Omega-3脂肪酸药物Vascepa（AMR-101）。
Strawberry Fields REIT, Inc.是一家专注于医疗类不动产的房地产投资信托，核心资产包含专业护理机构、老年生活社区及医疗办公大楼，业务主要覆盖美国各地市场，为医疗服务商及养老运营主体提供物业支持。
AMRN vs STRW — 直观对比
营收规模更大
AMRN
是对方的1.1倍
$40.1M
营收增速更快
STRW
高出24.5%
7.0%
净利率更高
STRW
高出28.3%
-23.3%
两年增速更快
STRW
近两年复合增速
-18.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $45.1M | $40.1M |
| 净利润 | $-10.5M | $2.0M |
| 毛利率 | — | — |
| 营业利润率 | 35.5% | 52.4% |
| 净利率 | -23.3% | 5.0% |
| 营收同比 | 7.0% | 31.5% |
| 净利润同比 | 33.0% | 37.6% |
| 每股收益（稀释后） | — | $0.15 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMRNSTRW
| Q1 26 | $45.1M | — | ||
| Q4 25 | $49.2M | $40.1M | ||
| Q3 25 | $49.7M | $39.7M | ||
| Q2 25 | $72.7M | $37.9M | ||
| Q1 25 | $42.0M | $37.3M | ||
| Q4 24 | $62.3M | $30.5M | ||
| Q3 24 | $42.3M | $29.5M | ||
| Q2 24 | $67.5M | $29.3M |
净利润AMRNSTRW
| Q1 26 | $-10.5M | — | ||
| Q4 25 | $-1.2M | $2.0M | ||
| Q3 25 | $-7.7M | $2.0M | ||
| Q2 25 | $-14.1M | $2.0M | ||
| Q1 25 | $-15.7M | $1.6M | ||
| Q4 24 | $-48.6M | $1.5M | ||
| Q3 24 | $-25.1M | $944.0K | ||
| Q2 24 | $1.5M | $938.0K |
毛利率AMRNSTRW
| Q1 26 | — | — | ||
| Q4 25 | 47.1% | — | ||
| Q3 25 | 44.7% | — | ||
| Q2 25 | 69.2% | — | ||
| Q1 25 | 59.8% | — | ||
| Q4 24 | -15.4% | — | ||
| Q3 24 | 38.5% | — | ||
| Q2 24 | 63.4% | — |
营业利润率AMRNSTRW
| Q1 26 | 35.5% | — | ||
| Q4 25 | -12.9% | 52.4% | ||
| Q3 25 | -22.4% | 56.6% | ||
| Q2 25 | -22.0% | 54.5% | ||
| Q1 25 | -39.9% | 54.1% | ||
| Q4 24 | -84.3% | 51.5% | ||
| Q3 24 | -59.5% | 54.4% | ||
| Q2 24 | -0.8% | 52.3% |
净利率AMRNSTRW
| Q1 26 | -23.3% | — | ||
| Q4 25 | -2.5% | 5.0% | ||
| Q3 25 | -15.6% | 5.1% | ||
| Q2 25 | -19.4% | 5.2% | ||
| Q1 25 | -37.4% | 4.2% | ||
| Q4 24 | -78.0% | 4.8% | ||
| Q3 24 | -59.4% | 3.2% | ||
| Q2 24 | 2.3% | 3.2% |
每股收益（稀释后）AMRNSTRW
| Q1 26 | — | — | ||
| Q4 25 | $0.00 | $0.15 | ||
| Q3 25 | $-0.02 | $0.16 | ||
| Q2 25 | $-0.03 | $0.16 | ||
| Q1 25 | $-0.04 | $0.13 | ||
| Q4 24 | $-0.12 | $0.17 | ||
| Q3 24 | $-0.06 | $0.14 | ||
| Q2 24 | $0.00 | $0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $307.8M | $31.8M |
| 总债务越低越好 | — | $794.7M |
| 股东权益账面价值 | — | $12.1M |
| 总资产 | $645.8M | $885.2M |
| 负债/权益比越低杠杆越低 | — | 65.64× |
8季度趋势，按日历期对齐
现金及短期投资AMRNSTRW
| Q1 26 | $307.8M | — | ||
| Q4 25 | $302.6M | $31.8M | ||
| Q3 25 | $286.6M | $19.8M | ||
| Q2 25 | $298.7M | $96.3M | ||
| Q1 25 | $281.8M | $42.3M | ||
| Q4 24 | $294.2M | $48.4M | ||
| Q3 24 | $305.7M | $29.3M | ||
| Q2 24 | $306.7M | $16.1M |
总债务AMRNSTRW
| Q1 26 | — | — | ||
| Q4 25 | — | $794.7M | ||
| Q3 25 | — | $779.4M | ||
| Q2 25 | — | $794.1M | ||
| Q1 25 | — | $715.5M | ||
| Q4 24 | — | $673.9M | ||
| Q3 24 | — | $584.5M | ||
| Q2 24 | — | $555.0M |
股东权益AMRNSTRW
| Q1 26 | — | — | ||
| Q4 25 | $459.3M | $12.1M | ||
| Q3 25 | $458.9M | $14.2M | ||
| Q2 25 | $464.9M | $15.5M | ||
| Q1 25 | $473.7M | $19.6M | ||
| Q4 24 | $486.2M | $18.2M | ||
| Q3 24 | $531.4M | $12.6M | ||
| Q2 24 | $551.9M | $7.4M |
总资产AMRNSTRW
| Q1 26 | $645.8M | — | ||
| Q4 25 | $670.8M | $885.2M | ||
| Q3 25 | $659.8M | $880.6M | ||
| Q2 25 | $670.1M | $897.3M | ||
| Q1 25 | $655.7M | $834.8M | ||
| Q4 24 | $685.3M | $787.6M | ||
| Q3 24 | $750.6M | $661.5M | ||
| Q2 24 | $799.9M | $635.9M |
负债/权益比AMRNSTRW
| Q1 26 | — | — | ||
| Q4 25 | — | 65.64× | ||
| Q3 25 | — | 54.70× | ||
| Q2 25 | — | 51.26× | ||
| Q1 25 | — | 36.47× | ||
| Q4 24 | — | 37.09× | ||
| Q3 24 | — | 46.34× | ||
| Q2 24 | — | 74.61× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $90.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 44.62× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流AMRNSTRW
| Q1 26 | — | — | ||
| Q4 25 | $15.3M | $90.0M | ||
| Q3 25 | $-12.7M | $20.7M | ||
| Q2 25 | $16.6M | $29.8M | ||
| Q1 25 | $-12.5M | $19.0M | ||
| Q4 24 | $-13.3M | $59.3M | ||
| Q3 24 | $-2.4M | $11.8M | ||
| Q2 24 | $-2.7M | $20.6M |
现金转化率AMRNSTRW
| Q1 26 | — | — | ||
| Q4 25 | — | 44.62× | ||
| Q3 25 | — | 10.26× | ||
| Q2 25 | — | 15.24× | ||
| Q1 25 | — | 11.97× | ||
| Q4 24 | — | 40.44× | ||
| Q3 24 | — | 12.53× | ||
| Q2 24 | -1.81× | 21.93× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMRN
| U.S | $35.6M | 79% |
| Europe | $4.9M | 11% |
| Rest-of-World (ROW) | $2.8M | 6% |
| Licensing & Royalties | $1.8M | 4% |
STRW
暂无分部数据
